Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The causes of human
amyotrophic lateral sclerosis
(
ALS
) and the spinal muscular atrophies (SMA) are, almost without exception, unknown. This ignorance has stimulated the search for animal models to obtain insight into the etiology, pathogenesis and biochemical mechanisms underlying the human disorders. None of the 38 animal models, described in this review, provides an exact animal copy of a specific human motor neuron disease. Most of the models reproduce certain structural or physiological aspects of their human counterparts. The various experimental models can be classified according to the pathogenetic mechanism involved and according to the structural changes observed. Models based on experimentally induced disease, include heavy metals and trace elements (lead intoxication in guinea pigs, rabbits, rats, cats and primates; mercury intoxication in rats; aluminium intoxication in rabbits; swayback in goat kids; calcium and magnesium deficient rabbits and primates and calcium deficient cynomolgus monkeys), toxins (IDPN, vincristine, vinblastine, podophyllotoxin, colchicine, maytansine, maytanprine, L-BMAA, lectins, adriamycin), nutritional factors (ascorbic acid deficient guinea pigs), virus infection (spongiform polioencephalomyelitis, attenuated poliovirus,
lactate dehydrogenase
-elevating virus), and immunological factors (immunization with motor neurons). Hereditary models comprise hereditary canine spinal muscular atrophy, hereditary neurogenic amyotrophy in the pointer dog, Stockard paralysis, Swedish Lapland dog paralysis, "wobbler" mouse, "shaker" calf, and hereditary spinal muscular atrophy in zebra foals, crossbred rabbits,
...
PMID:Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. 267 Dec 67
Dissociated human spinal cord cells were grown in monolayer cultures in the presence of serum from normal controls or from patients with
ALS
or other neurologic diseases. After 20 to 24 days, the levels of choline acetyltransferase, glutamic acid decarboxylase, and
lactate dehydrogenase
activities were determined in the cultures. On the basis of these biochemical measurements, there was no detectable difference between the effects of the three types of serum on the cultures.
...
PMID:ALS serum has no effect on three enzymatic activities in cultured human spinal cord neurons. 396 Mar 35
Enzyme activities of the energy supplying metabolism were investigated in muscle specimens of brachial biceps, deltoid or anterior tibial muscles of patients with traumatic nerve lesions, polyneuropathies, Charcot-Marie-Tooth disease,
amyotrophic lateral sclerosis
, spinal muscular atrophy and hemiparesis. The key enzymes of glycogenolysis (glycogen phosphorylase), glycolysis (triosephosphate dehydrogenase,
lactate dehydrogenase
), alpha-glycerophosphate cycle (alpha-glycerophosphate dehydrogenase), beta-oxidation of fatty acids (beta-hydroxy-acyl-CoA-dehydrogenase), citrate acid cycle (citrate synthase, malate dehydrogenase), hexokinase reaction (hexokinase) and pentosephosphate shunt (6-phosphogluconate dehydrogenase) were measured. The present study shows that in case of disorders of the lower motor neuron--especially those with impaired axoplasmic transport--changes in the enzyme patterns of muscles occur at an early stage. The glycolytic enzyme activities are of particular significance because they are the most sensitive indicators of the onset, extent and course of neurogenic atrophy. There is a good correlation between severity of the lesion, functional state of the muscles and reduction of these enzyme activities. In case of traumatic nerve lesions re-innervation can prevent a permanent reduction of glycolytic enzymes only if it occurs during the first months after denervation. In all cases in which operative revision is considered, it is therefore not advisible to wait since the regenerative capacity of the motor neuron is not the only limiting factor but also the biochemical and morphological changes in the muscle fibre. These are permanent after long lasting denervation without re-innervation within the first months. Primary neuroaxonal degeneration of the nerve fibre which was found in the majority of our alcoholic patients obviously impairs the metabolism of the muscle to a greater extent than primary demyelination most frequently observed in diabetics with polyneuropathy. Corresponding to the chronic course of the illness over years and to the severity of the pareses, drastic reduction in the activities of glycolytic enzymes was found in patients with Charcot-Marie-Tooth disease. Simultaneously the activity of 6-phosphogluconate dehydrogenase was significantly increased as a result of the chronic neurogenic lesion of the muscle fibres. Follow-up during the treatment of diseases of the lower motor neuron can be performed because the enzyme activities can be measured even in small muscle specimens. In patients with hemiparesis slight but not significant reduction in the glycolytic enzyme activities was found by comparison with a normal control group. We assume that this reduction is due to general inactivity which is caused by the movement disorder rather than to the particular influence of the upper motor neuron.
...
PMID:[Biochemical studies on muscles in neurogenic atrophies and central paralysis. Studies of the trophic functions of neurons]. 742 10
The neurotoxicity of glutamate has recently been postulated to participate in the pathogenesis of
amyotrophic lateral sclerosis
(
ALS
), and branched-chain amino acids have been proposed as possible therapeutic compounds for this disease. This study was undertaken to investigate whether branched-chain amino acids have any protective effect on cultured neurons exposed to glutamate. Primary cultures of cerebral neurons were prepared from fetal rats, using an established technique. For the assessment of glutamate toxicity, photomicrographs were taken before and after glutamate exposure both with phase-contrast and with bright field following incubation in trypan blue, a dye normally excluded by healthy cells. The activity of
lactate dehydrogenase
released from damaged cells was also measured. Exposure to glutamate in various concentrations was carried out, and leucine, isoleucine and varine, each separately, were added in advance to culture dishes. Glutamate neurotoxicity was confirmed, but no protective effect of branched-chain amino acids was observed. Although possible clinical benefit of branched-chain amino acids in
ALS
may not be denied, they do not prevent glutamate neurotoxicity in cultured cerebral neurons.
...
PMID:[Effect of branched-chain amino acids on glutamate neurotoxicity in primary cultured rat cerebral neurons]. 761 70
Plant amino acids beta-N-oxalylamino-L-alanine (L-BOAA, present in Lathyrus sativus) and beta-N-methylamino-L-alanine (L-BMAA, present in Cycas circinalis) have been implicated in the pathogenesis of human neurological disorders lathyrism and
amyotrophic lateral sclerosis
-Parkinson's dementia complex of Guam (ALS-PD), respectively. In view of the conflicting reports that have emerged on the role of L-BMAA in
ALS
-PD, we reinvestigated the comparative toxicity of L-BMAA and L-BOAA. We report here the potent toxicity of L-BOAA as examined in an in vitro model consisting of sagittal slices of mouse brain. Incubation of sagittal slices of mouse brain with L-BOAA (1 pM) resulted in significant leakage of
lactate dehydrogenase
(
LDH
) and potassium from the slices into the medium. Under similar conditions, L-BMAA-induced
LDH
leakage from the slices into the medium was observed only at very high concentration of the toxin, namely 1 mM. N-Methyl-D-aspartate (NMDA) receptor antagonists ameliorated the toxic effects of L-BMAA, while non-NMDA receptor antagonists (quinoxalinediones) protected against the toxicity of L-BOAA. Incubation of slices with L-BOAA for 1 h resulted in extensive vacuolation and degeneration of neurons in the thalamus and brain stem, and to a lesser extent in the hippocampus and cerebellar nuclei. The large sized neurons appeared to be affected to a greater extent than the smaller ones. The neurons in other areas of the brain also revealed variable degree of degeneration with swelling of axons and dendrites.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Billion-fold difference in the toxic potencies of two excitatory plant amino acids, L-BOAA and L-BMAA: biochemical and morphological studies using mouse brain slices. 790 22
Patients with
amyotrophic lateral sclerosis
possess antibodies (
ALS
IgGs) that bind to L-type skeletal muscle voltage-gated calcium channels (VGCCs) and inhibit L-type calcium current. To determine whether interaction of
ALS
IgGs with neuronal VGCCs might influence motoneuron survival, we used a motoneuron-neuroblastoma hybrid (VSC 4.1) cell line expressing binding sites for inhibitors of L-, N-, and P-type VGCCs. Using direct viable cell counts, quantitation of propidium iodide- and fluorescein diacetate-labeled cells, and
lactate dehydrogenase
release to assess cell survival, we document that
ALS
IgG kills 40-70% of cAMP-differentiated VSC 4.1 cells within 2 days.
ALS
IgG-mediated cytotoxicity is dependent on extracellular calcium and is prevented by peptide antagonists of N- or P-type VGCCs but not by dihydropyridine modulators of L-type VGCCs. Preincubating IgG with purified intact L-type VGCC or with isolated VGCC alpha 1 subunit also blocks
ALS
IgG-mediated cytotoxicity. These results suggest that
ALS
IgG may directly lead to motoneuron cell death by a mechanism requiring extracellular calcium and mediated by neuronal-type calcium channels.
...
PMID:Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. 815 58
The elevation of taurine level in the central nervous system of patients with
amyotrophic lateral sclerosis
(
ALS
) indicates the presence of derangement in sulfur amino acid metabolism in this disease. In the metabolic pathway from methionine to taurine and in its branch pathways, excitatory sulfur amino acids are formed. These are cysteine (Cys), cysteine sulfinic acid (CSA), cysteic acid (CA), homocysteine sulfinic acid (HCSA), homocysteic acid (HCA) and S-sulfo cysteine (SC). This study was undertaken to investigate whether these excitatory sulfur amino acids have any cytotoxicity, since excitotoxicity has recently been implicated in the pathogenesis of
ALS
. Primary cultures of cerebral neurons were prepared from fetal rats, using an established method. Neuronal cell injury was assessed by examination of cultures with phase-contrast microscopy and with bright-field examination of trypan blue staining, a dye staining non-viable cells. The morphological estimate of cell injury was confirmed by the measurement of the activity of
lactate dehydrogenase
, released from damaged or destroyed cells, in the extracellular fluid. This convenient and quantitative index invariably correlated with the morphological estimates. Among the 6 sulfur amino acids, CSA and HCSA showed cytotoxicity, while Cys, CA, HCA and SC did not. K0.5 of CSA was 80 microM, and that of HCSA was 300 microM. The cytotoxicity of CSA was stronger than that of glutamate, K0.5 of which was 100 microM. Relevance of these excitotoxic sulfur amino acids, especially CSA to the pathogenesis of
ALS
has not been studied. This possibility will be a subject for future study.
...
PMID:[Cytotoxicity of excitatory sulfur amino acids in primary cultured rat cerebral neurons]. 882 91
In the neural tissue of patients with
amyotrophic lateral sclerosis
(
ALS
), the elevation of taurine, the final product of the metabolic pathway of sulfur amino acids (SAAs), has been reported, suggesting that excitatory SAAs, the intermediates of this pathway, could also be increased. This study was undertaken to evaluate whether excitatory SAAs have the ability to inhibit cystine uptake. Since immature neurons have not yet expressed the receptor channels, they are not susceptible to excitotoxicity. Inhibition of cystine transport leads to a depletion of glutathione, and results in cell death due to oxidative stress. Cell cultures were obtained from the cerebral cortex of fetal Wistar rats. Cytotoxicity studies were performed 48 hours after plating by addition of the culture medium containing SAAs; cysteine sulfinic acid, cysteic acid, homocysteine sulfinic acid (HCSA), homocysteic acid (HCA) and S-sulfocysteine. Cell death was quantified by the release of the cytosolic enzyme
lactate dehydrogenase
, and single cell assessment of apoptosis was carried out by staining cells with acridine orange, DNA isolation and agarose gel electrophoresis were also performed. Protection of cycloheximide, a protein synthesis inhibitor, against non-receptor mediated excitatory SAA cytotoxicity was also assessed. HCA and HCSA showed cytotoxicity, the morphology and biochemistry of which were compatible to apoptosis. It will be a subject for future study to examine whether this mechanism of cell death is primarily present in
ALS
.
...
PMID:[Apoptosis induced by excitatory sulfur amino acids in primary cultured rat immature cerebral neurons]. 1034 43
Our earlier studies have shown that cerebrospinal fluid (CSF) of patients with
amyotrophic lateral sclerosis
(
ALS
), when intrathecally injected into the neonatal rats, produces an aberrant phosphorylation of neurofilaments (NF) in the ventral horn neurons and reactive astrogliosis in the spinal cord. We wanted to investigate the effect of cyclophosphamide in the spinal cords of neonatal rats exposed to
ALS
-CSF. A single dose (5 microg in 5 microl saline) of cyclophosphamide was injected, 24 h after the administration of CSF samples from
ALS
and non-
ALS
neurological patients into the spinal subarachnoid space of 3-day-old rat pups. Rats were sacrificed after a period of 24 h, and stained with antibodies against the phosphorylated NF (SMI-31 antibody) and glial fibrillary acidic protein (GFAP). Cyclophosphamide treatment resulted in a 50% decrease in the number of SMI-31 stained neuronal soma in ventral horns of spinal cords of
ALS
-CSF exposed rats. This was accompanied by a decrease in the number of GFAP immunoreactive astrocytes. Furthermore,
lactate dehydrogenase
(
LDH
) activity was also decreased significantly, following cyclophosphamide treatment. These results suggest that cyclophosphamide could exert a neuroprotective effect against the neurotoxic action of factor(s) present in the
ALS
-CSF.
...
PMID:Cyclophosphamide attenuates the degenerative changes induced by CSF from patients with amyotrophic lateral sclerosis in the neonatal rat spinal cord. 1131 Dec 91
Age-dependent poliomyelitis (ADPM) is a virally induced neuroparalytic disease of mice and a model for
amyotrophic lateral sclerosis
(
ALS
). ADPM is triggered in genetically susceptible mice by immunosuppression and infection with
lactate dehydrogenase
-elevating virus (LDV). Both ADPM and
ALS
are characterized by progressive degeneration of anterior horn motor neurons, and death in
ALS
is usually associated with respiratory failure. To assess respiratory function in ADPM, we investigated ventilation in conscious control and LDV-infected C58/J mice breathing air and then 6.5% CO(2) in O(2). Three days after LDV infection, ventilation in response to CO(2) was half of that compared to the uninfected state, but become normalized by 10 days. Administration of cyclophosphamide alone (200 mg/kg, ip), an immunosuppressant, had no effect on ventilation. Induction of ADPM by concomitant administration of LDV to cyclophosphamide-treated mice resulted in altered gait, hindlimb paralysis, wasting, decreased metabolism, and decreased body temperature by 4 degrees C relative to controls. Compared to baseline values, mice with ADPM had decreased tidal volume and ventilation while breathing air, and while exposed to the CO(2) challenge they were unable to increase tidal volume, frequency of breathing, or ventilation. Using in situ hybridization, LDV replication was noted within the spinal cord, brain, and lung, but not in the diaphragm. Thus, respiratory failure is a contributory mechanism leading to death in ADPM and is associated with LDV replication in the CNS and lung. This animal model may be useful to investigate physiological and molecular mechanisms associated with the development of respiratory failure in neurodegenerative diseases.
...
PMID:Age-dependent poliomyelitis in mice is associated with respiratory failure and viral replication in the central nervous system and lung. 1151
1
2
3
4
Next >>